Publication:
Can we afford to overlook the cost of avoidable complications in type 2 diabetes: a health economic analysis to evaluate what is the 'cost of not' acting in Turkey?

dc.contributor.coauthorSolorzano, J.
dc.contributor.coauthorMihajlovi, C. J.
dc.contributor.coauthorDinc, M.
dc.contributor.coauthorErdogan, A.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorDeyneli, Oğuzhan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:59:33Z
dc.date.issued2022
dc.description.indexedbyWOS
dc.description.issue12
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume25
dc.identifier.eissn1524-4733
dc.identifier.issn1098-3015
dc.identifier.quartileQ1
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1098301522025074?via%3Dihub
dc.identifier.urihttps://hdl.handle.net/20.500.14288/15659
dc.identifier.wos897594900271
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofValue in Health
dc.subjectEconomics
dc.subjectHealth care sciences services
dc.subjectHealth policy services
dc.titleCan we afford to overlook the cost of avoidable complications in type 2 diabetes: a health economic analysis to evaluate what is the 'cost of not' acting in Turkey?
dc.typeMeeting Abstract
dspace.entity.typePublication
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files